Article Information
History
- July 11, 2022.
Article Versions
- Version 1 (February 19, 2022 - 22:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Catherine Anscombe*,1,2,
- Samantha Lissauer*,1,4,†,
- Herbert Thole*,1,
- Jamie Rylance1,2,
- Dingase Dula1,
- Mavis Menyere1,
- Belson Kutambe1,
- Charlotte van der Veer1,11,
- Tamara Phiri9,
- Ndaziona P. Banda8,
- Kwazizira S. Mndolo9,
- Kelvin Mponda9,
- Chimota Phiri9,
- Jane Mallewa8,
- Mulinda Nyirenda8,9,
- Grace Katha9,
- Henry Mwandumba1,2,8,
- Stephen B. Gordon1,2,
- Kondwani C. Jambo1,2,8,
- Jennifer Cornick1,4,
- Nicholas Feasey1,2,
- Kayla G. Barnes+,1,4,5,6,7,
- Ben Morton+,1,2,10,
- Philip M. Ashton+&,1,4,
- Blantyre COVID-19 Consortium%
- 1Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi
- 2Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- 3Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
- 4Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom
- 5Harvard School of Public Health, Boston, USA
- 6Broad Institute of MIT and Harvard, Cambridge, USA
- 7University of Glasgow MRC Centre for Virus Research, Glasgow, UK
- 8Kamuzu University of Health Sciences (formerly University of Malawi-College of Medicine) Blantyre, Malawi
- 9Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi
- 10Liverpool University Hospitals Foundation Trust, Liverpool, UK
- 11Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom